NP 01A

Also Known As:

10,10-dimethyl-11-deoxy-6-keto-PGE1; 10,10-dimethyl-11-deoxy-6-keto-prostaglandin E1; NP-01-A; NP01A; Prost-13-en-1-oic acid, 15-hydroxy-10,10-dimethyl-6,9-dioxo-, (13E,15S)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Prostaglandins E: 2673
        Alprostadil: 3107
        NP 01A: 1
    - Monounsaturated Fatty Acids: 676
      - Alprostadil: 3107
        NP 01A: 1
Biological Factors: 2472
- Inflammation Mediators: 1113
  - Autacoids: 276
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Prostaglandins E: 2673
        Alprostadil: 3107
        NP 01A: 1

Related Diseases

1.	Urinary Bladder Neoplasms (Bladder Cancer) 08/01/1985 - "The cytotoxic effects of the prostaglandin derivatives, NP01A, NP07A and NP13A (Nihoniyakuhin Kogyo Co., Ltd., Toyama, Japan) on asynchronous cells of an established human bladder cancer cells line, KK-47, have been investigated using an in vitro colony formation technique. "

Related Drugs and Biologics

1.	Prostaglandins
2.	NP 13 A
3.	NP 07 A